Compare this test’s laboratory options
Antithrombin III Activity
Access Labcorp Draw1 test optionFrom $85.18
Antithrombin III Activity
Access Labcorp DrawWhat this laboratory test evaluates
DetailsThis test evaluates the activity of antithrombin in the blood. It is used to help diagnose antithrombin deficiencies and to monitor the effectiveness of anticoagulant therapy in patients with clotting disorders.
What type of sample is required for this test?Plasma
Test ResourcesFor more information, please consult your healthcare provider.
Additional test information
This test evaluates the activity of antithrombin in the blood. It is used to help diagnose antithrombin deficiencies and to monitor the effectiveness of anticoagulant therapy in patients with clotting disorders.
Collection and processing
- Sample type: Plasma
- Fasting: No
- Estimated laboratory processing: Results should arrive 2 – 3 business days after the lab receives samples.
How Sunridge uses laboratory information
Sunridge considers the medical question, symptoms, history, medications, prior results, and whether the finding could change care before recommending testing. A laboratory result is not interpreted in isolation and does not establish a diagnosis by itself.
Before requesting this test
Availability, collection requirements, eligibility, and processing estimates can change. Sunridge reviews each request and, when appropriate, creates the order through Fullscript. Follow the current instructions supplied with the approved order.
About this test
DetailsThis test evaluates the activity of antithrombin in the blood. It is used to help diagnose antithrombin deficiencies and to monitor the effectiveness of anticoagulant therapy in patients with clotting disorders.
What type of sample is required for this test?Plasma
Test ResourcesFor more information, please consult your healthcare provider.
Additional details
This test evaluates the activity of antithrombin in the blood. It is used to help diagnose antithrombin deficiencies and to monitor the effectiveness of anticoagulant therapy in patients with clotting disorders.
Highlighted health areas
- Hematology
Biomarkers and report focus
The exact analytes and report format can change. Confirm the current contents in the Fullscript order before payment.
- Antithrombin III Activity